1. New Zealand Guidelines Group. Identification of Common Mental Disorders and Management of Depression in Primary care. An Evidence-Based Best Practice Guideline. Wellington: New Zealand Guidelines Group; 2008.
  2. Ministry of Health. Te Puāwaiwhero: The Second Māori mental health and addiction national strategic framework 2008-2015. Wellington: Ministry of Health; 2008.
  3. Baxter J. Maori Mental Health Needs Profile. A review of the Evidence. Palmerston North; Te Rau Matatini; 2008.
  4. Minister of Health. Te Kokiri:The Mental Health and Addiction Action Plan 2006-2015. Wellington: Ministry of Health; 2006.
  5. Ministry of Health. Statement of Intent: 2007-2010. Wellington: Ministry of Health; 2007.
  6. Oakley Browne MA, Wells JE, Scott KM (eds). Te Rau Hinengaro-The Mental Health Survey. Wellington: Ministry of Health; 2006.
  7. Minister of Health. Te Tāhuhu – Improving Mental Health 2005-2015: The Second New Zealand Mental Health and Addiction Plan. Wellington: Ministry of Health; 2005.
  8. Bpacnz. Maori Health. Best Practice Journal 2008;13.
  9. Goodyear-Smith F, Coupe NM, Arroll B, Elley CR, Sullivan S, McGill A. Case finding of lifestyle and mental health disorders in primary care: validation of the ‘CHAT’ tool. Br J Gen Pract 2008;58:26-31
  10. The Australian Medicines Handbook, Adelaide; 2006.
  11. Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic. Version 6. Melbourne: Therapeutic Guidelines Limited; 2008.
  12. Bpacnz. Changing to a generic drug. Best Practice Journal 2007; SpEd:26-9.
  13. de Abajo FJ and García-Rodríguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: Interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65:795-803.
  14. Medsafe Editorial Team. SSRI Use in Pregnancy - Collaborative Decision-Making is Key. Prescriber Update 2008;29(1):7-8.